Pfizer Defends Nigerian Drug Study
NEW YORK-Pharmaceutical giant Pfizer was left defending itself after an article in The Washington Post found the company reportedly did not follow the necessary procedures before beginning their study of the drug Trovan.
Company officials said they were "proud of the way the study was conducted," although there is now a lawsuit filed in the US District Court of New York on behalf of 30 children who participated in the study. They argue the drug, known as trovafloxacin also, was responsible for the deaths and brain damage of children during a 1996 meningitis outbreak in Nigeria. There were more than 200 children who participated in the study, which took place during an epidemic that killed more than 15,000 Africans.
The lawsuit alleges that Pfizer officials rushed important steps to begin the study, therefore violating international law, federal regulations, and medical ethics.
The article, which ran as a series highlighting medical testing abroad by American pharmaceutical companies, showed that the company did not seek approval from an Nigerian medical ethics committee before starting testing.
Trovan, which was approved by the US Food and Drug Administration (FDA) in 1997, was designed to treat many infections, However, after cases of liver failure, its uses was restricted in 1999.
Information from www.washingtonpost.com
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
